M.Sc. (Organic Chemistry) with extensive executive experience from the pharma, biotech, diagnostics and medtech industries - R&D, BD and Operations.
Ole Henrik Eriksen is a highly experienced professional with 39.9 years of work experience in various industries such as pharma, biotech, diagnostics, and medtech. He holds an M.Sc. in Organic Chemistry and has extensive executive experience in the pharma, biotech, diagnostics, and medtech industries. Ole has held key positions such as Chief Business Development Officer, Founder, and Chairman of the Board. He has worked with renowned companies like Navamedic ASA, Weifa AS, and Genetic Analysis AS. Ole is known for his expertise in R&D, entrepreneurship, and business strategy. He is currently based in Oslo, Norway.
Genetic Analysis AS (GA) is positioned to become a world leader within the field of molecular in-vitro diagnostics of diseases related to gut imbalances. Based on the patented DNA-based GA-map® platform technology, profiles of patient’s gut microbiota is quickly generated and can be related to various health conditions. Our first product, the GA-map® Dysbiosis Test helps Gastroenterologists to measure and monitor gut microbiota status in patients with Irritable Bowel Syndrome (IBS). This is the first dysbiosis test which is commercially available, standardised, CE-marked and clinically validated (50 clinical trials + 30 publications). Further clinical applications for the tests are in areas such as diagnosis, disease severity course, treatment prediction and monitoring within both IBS (irritable bowel syndrome) and IBD (inflammatory bowel disease) where the need of clinical data and validation is required. GA is thus very active in these fields. Other areas of interest are metabolic disease including diabetes type 2
Weifa is Norway's leading consumer health company. We supply real value through medicines, lifestyle products and solutions that address the essential needs of consumers, customers and professional partners. Weifa was founded in 1940 and now employs about 30 highly qualified people at our headquarters in Oslo. The company has a strong position in Norway and is the market leader in pain relief, with well-established brands such as Paracet and Ibux. We are also present in other key areas such as dietary supplements and treatment for colds and respiratory problems.
NeoRad is a Norwegian medical device company built to improve patient care by providing quality, innovative and high-value medical products to the field of radiology. Our lead product, SimpliCT, aids radiologists in treating patients more accurately, quicker and by using less harmful radiation. Increased focus on image guided procedures, especially oncologic procedures are market drivers. “ Laser guidance significantly reduces fluoroscopy time and effective patient dose without affecting procedure time.” Maarten Kroes, MSc, Radboud University Nijmegen Medical Center, Holland, 2011
We found 2 Ole Henrik Eriksen's email addresses
We found 3 Ole Henrik Eriksen's phone numbers
Ole Henrik Eriksen's social media include: Linkedin,
Ole Henrik Eriksen works for Navamedic ASA
Ole Henrik Eriksen's role in Navamedic ASA is Chief Business Development Officer
Ole Henrik Eriksen works in the industry of
Ole Henrik Eriksen's colleagues are
Ole Henrik Eriksen's latest job experience is Chief Business Development Officer at Navamedic ASA
Ole Henrik Eriksen's latest education in Norwegian University of Science and Technology (NTNU)